171 related articles for article (PubMed ID: 21565426)
21. Simultaneous comparison of murine norovirus, feline calicivirus, coliphage MS2, and GII.4 norovirus to evaluate the efficacy of sodium hypochlorite against human norovirus on a fecally soiled stainless steel surface.
Park GW; Sobsey MD
Foodborne Pathog Dis; 2011 Sep; 8(9):1005-10. PubMed ID: 21457050
[TBL] [Abstract][Full Text] [Related]
22. The antiviral effect of 7-hydroxyisoflavone against Enterovirus 71 in vitro.
Wang HQ; Meng S; Li ZR; Peng ZG; Han YX; Guo SS; Cui XL; Li YH; Jiang JD
J Asian Nat Prod Res; 2013; 15(4):382-9. PubMed ID: 23464760
[TBL] [Abstract][Full Text] [Related]
23. Chlorine dioxide inactivation of enterovirus 71 in water and its impact on genomic targets.
Jin M; Shan J; Chen Z; Guo X; Shen Z; Qiu Z; Xue B; Wang Y; Zhu D; Wang X; Li J
Environ Sci Technol; 2013 May; 47(9):4590-7. PubMed ID: 23560857
[TBL] [Abstract][Full Text] [Related]
24. Detection and characterization of enterovirus associated with herpangina and hand, foot, and mouth disease in Seoul, Korea.
Park SH; Choi SS; Oh SA; Kim CK; Cho SJ; Lee JH; Ryu SH; Pak SH; Jung SK; Lee JI; Park GY; Choi SM; Chae YZ; Kang BH; Cheon DS; Kim HS
Clin Lab; 2011; 57(11-12):959-67. PubMed ID: 22239028
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of enterovirus 71 replication by an α-hydroxy-nitrile derivative NK-1.9k.
Wang Y; Cao L; Zhai Y; Ma J; Nie Q; Li T; Yin Z; Sun Y; Shang L
Antiviral Res; 2017 May; 141():91-100. PubMed ID: 28063993
[TBL] [Abstract][Full Text] [Related]
26. Status of research and development of vaccines for enterovirus 71.
Reed Z; Cardosa MJ
Vaccine; 2016 Jun; 34(26):2967-2970. PubMed ID: 26973065
[TBL] [Abstract][Full Text] [Related]
27. Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins.
Liu Q; Ku Z; Cai Y; Sun B; Leng Q; Huang Z
J Virol Methods; 2011 Apr; 173(1):115-20. PubMed ID: 21295614
[TBL] [Abstract][Full Text] [Related]
28. Human enterovirus 71 and hand, foot and mouth disease.
Wong SS; Yip CC; Lau SK; Yuen KY
Epidemiol Infect; 2010 Aug; 138(8):1071-89. PubMed ID: 20056019
[TBL] [Abstract][Full Text] [Related]
29. A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge.
Liu Q; Yan K; Feng Y; Huang X; Ku Z; Cai Y; Liu F; Shi J; Huang Z
Vaccine; 2012 Oct; 30(47):6642-8. PubMed ID: 22959985
[TBL] [Abstract][Full Text] [Related]
30. The inactivation of the non-enveloped enterovirus 71 (EV71) by a novel disinfectant gel formulation for topical use.
Ma HQ; Wang Y; Mao YH; Wang SY; Zhang YP; Zuo CQ; Liang SJ; Liu JW
Drug Dev Ind Pharm; 2019 Mar; 45(3):506-513. PubMed ID: 30574810
[TBL] [Abstract][Full Text] [Related]
31. Genetic changes of coxsackievirus A16 and enterovirus 71 isolated from hand, foot, and mouth disease patients in Toyama, Japan between 1981 and 2007.
Iwai M; Masaki A; Hasegawa S; Obara M; Horimoto E; Nakamura K; Tanaka Y; Endo K; Tanaka K; Ueda J; Shiraki K; Kurata T; Takizawa T
Jpn J Infect Dis; 2009 Jul; 62(4):254-9. PubMed ID: 19628900
[TBL] [Abstract][Full Text] [Related]
32. Antiviral activity of Paulownia tomentosa against enterovirus 71 of hand, foot, and mouth disease.
Ji P; Chen C; Hu Y; Zhan Z; Pan W; Li R; Li E; Ge HM; Yang G
Biol Pharm Bull; 2015; 38(1):1-6. PubMed ID: 25744451
[TBL] [Abstract][Full Text] [Related]
33. [Inactivation of Coxsackie group viruses in sodium hypochlorite].
Vorob'eva AM; Kul'skiĭ LA; Smirnova RS
Gig Sanit; 1978 Aug; (8):96-7. PubMed ID: 669366
[No Abstract] [Full Text] [Related]
34. Genetic diversity of enterovirus 71 isolated from cases of hand, foot and mouth disease in the 1997, 2000 and 2005 outbreaks, Peninsular Malaysia.
Chua KB; Chua BH; Lee CS; Chem YK; Ismail N; Kiyu A; Kumarasamy V
Malays J Pathol; 2007 Dec; 29(2):69-78. PubMed ID: 19108398
[TBL] [Abstract][Full Text] [Related]
35. Combining multiplex reverse transcription-PCR and a diagnostic microarray to detect and differentiate enterovirus 71 and coxsackievirus A16.
Chen TC; Chen GW; Hsiung CA; Yang JY; Shih SR; Lai YK; Juang JL
J Clin Microbiol; 2006 Jun; 44(6):2212-9. PubMed ID: 16757623
[TBL] [Abstract][Full Text] [Related]
36. Antigenicity, animal protective effect and genetic characteristics of candidate vaccine strains of enterovirus 71.
Mao Q; Li N; Yu X; Yao X; Li F; Lu F; Zhuang H; Liang Z; Wang J
Arch Virol; 2012 Jan; 157(1):37-41. PubMed ID: 21984267
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo protection against enterovirus 71 by an antisense phosphorothioate oligonucleotide.
Liu J; Zhou Z; Li K; Han M; Yang J; Wang S
Arch Virol; 2014 Sep; 159(9):2339-47. PubMed ID: 24756344
[TBL] [Abstract][Full Text] [Related]
38. Resistance of poliovirus 1 and enterovirus A71 against alcohol and other disinfectants.
Su Y; Han J; Li J; Ren Z; Huang L; Xu B; Wei Q
J Virol Methods; 2021 Dec; 298():114292. PubMed ID: 34536486
[TBL] [Abstract][Full Text] [Related]
39. A membrane-based quantitative carrier test to assess the virucidal activity of disinfectants and persistence of viruses on porous fomites.
Mocé-Llivina L; Papageorgiou GT; Jofre J
J Virol Methods; 2006 Jul; 135(1):49-55. PubMed ID: 16563525
[TBL] [Abstract][Full Text] [Related]
40. EV71: an emerging infectious disease vaccine target in the Far East?
Xu J; Qian Y; Wang S; Serrano JM; Li W; Huang Z; Lu S
Vaccine; 2010 Apr; 28(20):3516-21. PubMed ID: 20304038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
